DermTech Inc

+0.25 (+0.83%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)902.25M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.52 Million
Adjusted EPS-$0.64
See more estimates
10-Day MA$30.84
50-Day MA$33.70
200-Day MA$41.93
See more pivots

DermTech Inc Stock, NASDAQ:DMTK

11099 North Torrey Pines Road, Suite 100, La Jolla, California 92037
United States of America
Phone: +1.858.450.4222
Number of Employees: 118


DermTech, Inc. is a genomics company in dermatology, which engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate the early detection of skin cancers, assesses inflammatory diseases, and customizes drug treatments. Its products include adhesive skin collection kit, pigmented lesion assay, nevome, and carcinome. The company was founded in 1995 and is headquartered in La Jolla, CA.